Cargando…
Immune biomarker-based enrichment in sepsis trials
Autores principales: | Spinetti, Thibaud, Meisel, Christian, von Gunten, Stephan, Schefold, Joerg C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029545/ https://www.ncbi.nlm.nih.gov/pubmed/32075672 http://dx.doi.org/10.1186/s13054-020-2774-1 |
Ejemplares similares
-
Adrenomedullin in COVID-19 induced endotheliitis
por: Wilson, Darius Cameron, et al.
Publicado: (2020) -
Assessment of monocytic HLA-DR expression in ICU patients: analytical issues for multicentric flow cytometry studies
por: Monneret, Guillaume, et al.
Publicado: (2010) -
Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers
por: Pfortmueller, Carmen Andrea, et al.
Publicado: (2017) -
Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis
por: Poehlmann, Holger, et al.
Publicado: (2009) -
COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review
por: Pfortmueller, Carmen A., et al.
Publicado: (2021)